Departments of Endocrinology and Isotope Therapy Internal Medicine and Cardiology Nuclear Medicine, Military Institute of Medicine, Szaserów St. 128, Warsaw, Poland.
Clin Endocrinol (Oxf). 2011 Apr;74(4):501-7. doi: 10.1111/j.1365-2265.2010.03957.x.
Clinical significance of, and the need for, treatment in subclinical hyperthyroidism (sHT) is still a matter of debate. The aim of the study was to assess the impact of sHT on echocardiographic parameters.
Patients with endogenous sHT of nonautoimmune origin underwent full echocardiographic assessment at diagnosis and after restoring euthyroidism with radioiodine treatment.
Studied group consisted of 44 patients (37 women, 7 men), aged 22-65 years (mean 45·9±11·0).
Full echocardiographic assessment included estimation of cardiac chamber diameters and volume as well as cardiac contractility, according to the guidelines of the American Society of Echocardiography. Left ventricular mass was calculated according to Penn's convention. For estimation of left ventricle diastolic function, the following echocardiographic parameters were obtained: maximal early filling wave velocity (E), maximal late filling wave velocity (A), E/A ratio, isovolumetric relaxation time and early filling wave deceleration time.
In the studied group, phase of sHT was associated with increased volume of heart chambers, increased diameter of ascending aorta, increased left ventricle mass and disturbed left ventricle relaxation (P<0·05). The systolic function of the left ventricle was unaffected; however, the ejection time was shortened. The changes were reversible with restoring biochemical euthyroidism (P<0·05). Moreover, a significant correlation between some of the parameters and thyroid hormones concentration was demonstrated.
sHT was associated with significant changes in echocardiographic parameters, which may contribute to increased cardiovascular risk in these patients. The alterations were reversible with restoring biochemical euthyroidism, what supports the necessity of treatment introduction in sHT.
亚临床甲状腺功能亢进症(sHT)的临床意义和治疗需求仍存在争议。本研究旨在评估 sHT 对超声心动图参数的影响。
对非自身免疫源性内源性 sHT 患者进行超声心动图全面评估,在诊断时以及放射性碘治疗恢复甲状腺功能正常后进行。
研究组包括 44 例患者(37 名女性,7 名男性),年龄 22-65 岁(平均 45.9±11.0 岁)。
超声心动图全面评估包括根据美国超声心动图学会指南评估心腔直径和容积以及心脏收缩力。根据 Penn 共识计算左心室质量。为评估左心室舒张功能,获得以下超声心动图参数:最大早期充盈波速度(E)、最大晚期充盈波速度(A)、E/A 比值、等容舒张时间和早期充盈波减速时间。
在研究组中,sHT 阶段与心腔容积增加、升主动脉直径增加、左心室质量增加和左心室松弛功能障碍相关(P<0.05)。左心室收缩功能不受影响,但射血时间缩短。恢复生化甲状腺功能正常后,这些变化是可逆的(P<0.05)。此外,还证明了一些参数与甲状腺激素浓度之间存在显著相关性。
sHT 与超声心动图参数的显著变化相关,这些变化可能导致这些患者的心血管风险增加。恢复生化甲状腺功能正常后,这些改变是可逆的,这支持了 sHT 治疗的必要性。